Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2024-03-20 Capital/Financing Update
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure is a standard capital structure update related to financing instruments. Since it specifically details changes to conversion prices and the resulting impact on potential share counts, it falls under the 'Capital/Financing Update' category.
2024-03-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 1% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds into shares. It details the number of shares issued, the conversion price, and the impact on the total outstanding shares. This type of corporate action, involving the issuance of new shares resulting from the conversion of debt instruments, falls under the category of share capital changes.
2024-03-19 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Nexturn Bio. It outlines the date, location, and specific agenda items (approval of financial statements, election of directors, etc.). This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Nexturn Bioscience. It contains the meeting agenda, details on board member re-elections, and financial statements (balance sheet, income statement) provided as reference materials for shareholders to review prior to the meeting. This type of document is a standard Proxy Solicitation and Information Statement, which provides shareholders with the necessary information to vote on company matters.
2024-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies, citing audit and preparation requirements. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the results, it falls under the general regulatory filing category.
2024-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, details of the proxy solicitation, and the company's financial statements (balance sheet, income statement, etc.) as part of the disclosure requirements for shareholders. Since it is a formal solicitation document for a shareholder meeting, it falls under the Proxy Solicitation & Information Statement category.
2024-03-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.